clenoliximab clenoliximab clenoliximab (inn) is a monoclonal antibody against cd4. it acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis. the drug is a chimeric antibody from macaca irus and homo sapiens. clenoliximabmonoclonal antibodytypewhole antibodysourcechimeric (primate/human)targetcd4clinical dataatc codenoneidentifierscas number182912-58-9 ydrugbankdb06241 ychemspidernoneunii78evw7gx37 ny (what is this?) (verify)